Nextra® Help with Psoriasis & Eczema
Your skin is your largest organ. 80% of people have skin problems. At KEYS®, we create clean, safe, natural products without chemicals that solve these problems. KEYS products make you feel and look better. Articles like this are meant to help you in your journey for clean clear skin, Naturally.
Since the introduction of Keys Nextra® NeoRetinol last summer, our customers have reported extra fast relief of symptoms from Psoriasis and Eczema.
National Institutes of Health studies have outlined a combination of oral vitamin D supplementation and Retinol as a viable treatment of Psoriasis.
Further reports from Keys customers have also indicated that Nextra® has an immediate positive effect on Eczema symptoms.
Keys customers have long known that Keys products are based on natural remedies and wellness science. This makes them a group that we title self-experimenters. They will often take Keys products and use them in ways that make sense and are sometimes wildly different than we intended. So is true of reports from our customer about using Nextra NeoRetinol for skin disorders like dermatitis, Eczema, and Psoriasis.
Here is one of the many studies conducted by the National Institutes of health on using Retinol as a treatment of Psoriasis.
What are customers report about using Nextra NeoRetinol on their Eczema and Psoriasis:
Crusty patches were reduced significantly more quickly than Keys Tortuga.
Redness reduced significantly.
The itching was relieved much more quickly than with Keys MetaCare.
Combining oral Vitamin D with Nextra seemed to improve overall conditions
A few customers reported full reversal of rash and symptoms.
We have no way of testing these claims because we are not in any form of clinical trials. We have believed all along that Nextra® NeoRetinol has most, if not all, the properties of Retinol without the drastic side effects. It makes sense that it would be the same as Retinol for some more therapeutic uses. Said, you can try Nextra® for yourself to see if it helps you. As Always, Please be cautious and go slow to make sure that Nextra® or any other natural remedy helps you and your specific skin type.
From NIH PubMed®
Topical therapies for Psoriasis
To review current understandings of and approaches to topical psoriasis therapies and to assess their efficacies and adverse effects.
QUALITY OF EVIDENCE
Literature from 1987 to 2003, inclusive, was reviewed via MEDLINE using the search term “psoriasis” combined with “topical treatment.” Articles were prioritized based on their level of evidence, favoring double-blind, randomized controlled trials over other comparison studies. Other studies were included where level I research was unavailable. No level III research was included.
Psoriasis is very common and causes substantial morbidity. Because most Psoriasis is mild to moderate, patients are well suited to outpatient topical therapy. Advances in topical treatments for Psoriasis have kept pace with a rapidly evolving comprehension of its pathogenesis, making a review of current therapies useful for those who treat Psoriasis. While research supports continued reliance on corticosteroids as first-line therapy, comparable efficacy has been shown for vitamin D analogues and topical retinoids, albeit with a slight increase in adverse effects.
The combination of steroids and vitamin D analogues or topical retinoids is perhaps the most promising current treatment. It seems to have increased efficacy and fewer side effects.
EDITOR’S KEY POINTS
- Psoriasis is a psychologically and sometimes medically disabling condition affecting 1% to 3% of the population. Most patients are managed by family physicians.
- The goal of treatment is lifetime control. About 75% of patients have mild-to-moderate Psoriasis, amenable to topical treatment.
- Corticosteroids form the basis of treatment, with the best success and fewest side effects. Since they come in various potencies, they permit individualized treatment depending on the severity of the condition and site on the body. Pulsed delivery (once weekly) can minimize side effects.
- Other treatments include vitamin D analogues (calcipotriol), retinoids (tazarotene), anthralin (dithranol), tar compounds, or combinations (such as steroids and vitamin D).
Psoriasis is a psychosocially, and at times medically, debilitating disorder that affects 1% to 3% of the population worldwide. Although Psoriasis is undoubtedly distressing, affected individuals are typically otherwise healthy and thus well suited to thoughtful outpatient care.
Recent advances in our understanding of Psoriasis have provided parallel advances in topical treatments. Appropriate knowledge and use of these therapies are vital to dermatologists and family physicians caring for patients with Psoriasis.
Please Click Here to read the entire report and to enter the NIH PubMed® domain for further research.